Sangamo Therapeutics
SGMO
SGMO
185 hedge funds and large institutions have $860M invested in Sangamo Therapeutics in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 76 increasing their positions, 39 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
185
Holders Change
-2
Holders Change %
-1.07%
% of All Funds
4.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
76
Reduced
39
Closed
31
Calls
$26.2M
Puts
$15.7M
Net Calls
+$10.5M
Net Calls Change
+$2.07M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
$119M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
$39.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$20.5M |
| 4 |
BlackRock
New York
|
$102M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
$8.52M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
$300K |
| 2 |
State Street
Boston,
Massachusetts
|
$57.6M |
| 3 |
Renaissance Technologies
New York
|
$6.75M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
$3.19M |
| 5 |
D.E. Shaw & Co
New York
|
$0 |
